Subscribe Now

Stay up-to-date on the latest policy, research, and industry conversations that impact the future of biopharmaceutical innovation, delivered every Tuesday straight to your inbox.

Dig deeper on the discussions at #AMCP2024 with these top resources from NPC:

IRA Impact

NPC’s research and analysis offers important insights on the unintended consequences of the IRA. Access them now.

One-pager: Potential Unintended Consequences of the Inflation Reduction Act’s Medicare Drug Price Negotiation Program for Patients
AJMC study: Unintended Consequences of the Inflation Reduction Act: Clinical Development Toward Subsequent Indications
JAMA Health Forum study: Medicare Part D Coverage of Drugs Selected for the Drug Price Negotiation Program
NPC Comments: CMS Medicare DPNP

Value Assessment

While health system stakeholders work to define frameworks for measuring value, NPC's work can inform how to ensure patient access to treatments that will improve their health and quality of life. Learn more.

NPC at the AMCP 2024 Annual Meeting

Learn more about NPC's research presence at #AMCP2024 on our website, including highlights of session and poster presentations.

Read Now

Connect with the NPC #AMCP2024 team on LinkedIn